ZA912277B - The selective occupation of serotonin ic receptors - Google Patents

The selective occupation of serotonin ic receptors

Info

Publication number
ZA912277B
ZA912277B ZA912277A ZA912277A ZA912277B ZA 912277 B ZA912277 B ZA 912277B ZA 912277 A ZA912277 A ZA 912277A ZA 912277 A ZA912277 A ZA 912277A ZA 912277 B ZA912277 B ZA 912277B
Authority
ZA
South Africa
Prior art keywords
serotonin
receptors
selective occupation
occupation
selective
Prior art date
Application number
ZA912277A
Other languages
English (en)
Inventor
David Wayne Robertson
Wayne Robertson David
David Taiwai Wong
Taiwai Wong David
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA912277B publication Critical patent/ZA912277B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Addiction (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA912277A 1990-03-29 1991-03-26 The selective occupation of serotonin ic receptors ZA912277B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50106090A 1990-03-29 1990-03-29

Publications (1)

Publication Number Publication Date
ZA912277B true ZA912277B (en) 1992-11-25

Family

ID=23991998

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA912277A ZA912277B (en) 1990-03-29 1991-03-26 The selective occupation of serotonin ic receptors

Country Status (5)

Country Link
EP (1) EP0449562A3 (fr)
JP (1) JP3075577B2 (fr)
AU (1) AU633713B2 (fr)
CA (1) CA2039103A1 (fr)
ZA (1) ZA912277B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
DE69435095T2 (de) 1993-06-28 2009-07-02 Wyeth Neue Behandlungsmethoden durch Verwendung von Phenethylaminderivaten
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AU4100699A (en) * 1998-05-28 1999-12-13 Sepracor, Inc. Compositions and methods employing r(-) fluoxetine and other active ingredients
EP4103177A4 (fr) * 2020-02-11 2024-03-27 University of Virginia Patent Foundation Compositions et méthodes pour le traitement et/ou la prévention de maladies oculaires

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0294028B1 (fr) * 1987-05-04 1993-09-01 Eli Lilly And Company L'emploi de fluoxétine pour le traitement du diabète
ZA885824B (en) * 1987-08-14 1989-04-26 Merrell Dow Pharma Novel antidepressants
EP0386117B1 (fr) * 1987-10-22 1999-01-07 Massachusetts Institute Of Technology Traitement du syndrome de phase luteale tardive ou premenstruelle
US4868344A (en) * 1988-03-30 1989-09-19 Aldrich-Boranes, Inc. Novel process of producing phenyl or substituted phenylalkylamine pharmaceutical agents and novel chiral intermediates of high enantiomeric purity useful therein
CA2002483C (fr) * 1988-11-14 1999-08-17 Ray Ward Fuller Analogue de la fluoxetine

Also Published As

Publication number Publication date
CA2039103A1 (fr) 1991-09-30
AU633713B2 (en) 1993-02-04
JP3075577B2 (ja) 2000-08-14
EP0449562A3 (en) 1992-03-18
JPH04221309A (ja) 1992-08-11
AU7393491A (en) 1991-10-03
EP0449562A2 (fr) 1991-10-02

Similar Documents

Publication Publication Date Title
HU913074D0 (en) Fibrinogenic receptor antagonists
GB8403574D0 (en) Adenosine receptor antagonists
FI932477A (fi) Receptorer foer leukemi-inhiberande faktor
NO921040L (no) Stimulerende faktor for neu-reseptoren
GB8715050D0 (en) Melatonin antagonist
ZA912277B (en) The selective occupation of serotonin ic receptors
EP0542920A4 (en) Cannabinoid receptor
ZA874486B (en) Leukotriene antagonists
US5331305B1 (en) Chip network resistor
ZA912278B (en) Compounds affecting serotonin receptors
GR3000924T3 (en) Shower rod
KR970004975Y1 (en) Chip structure
ZA894097B (en) Alpha-adrenergic receptor antagonists
HU901857D0 (en) Selective adenosine receptors
GB2262272B (en) Suspended platform
FI930108A0 (fi) Imidazopyridin-paf-antagonister
ZA883601B (en) Vaspressin antagonists
ZA919960B (en) Serotonin antagonists.
DK0660832T3 (da) Serotoninreceptor-midler
IE891742L (en) Ó-adrenergic receptor antagonists
IE891741L (en) Ó-adrenergic receptor antagonists
PL283560A1 (en) Suspended platform
GB9126321D0 (en) Suspended platform
HU902429D0 (en) Migration signalling device
BR7201441U (pt) Taraxa integrada